Literature DB >> 9373254

The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells.

M Baghestanian1, R Hofbauer, H P Kiener, H C Bankl, F Wimazal, M Willheim, O Scheiner, W Füreder, M R Müller, D Bevec, K Lechner, P Valent.   

Abstract

Recent data suggest that mast cells (MC) are involved in the regulation of leukocyte accumulation in inflammatory reactions. In this study, expression of leukocyte-chemotactic peptides (chemokines) in purified human lung MC (n = 16) and a human mast cell line, HMC-1, was analyzed. Northern blotting and reverse transcriptase-polymerase chain reaction (RT-PCR) showed baseline expression of monocyte chemoattractant protein (MCP)-1 mRNA in unstimulated MC. Exposure of MC to recombinant stem cell factor (rhSCF, 100 ng/mL) or anti-IgE (10 microgram/mL) was followed by a substantial increase in expression of MCP-1 mRNA. Neither unstimulated nor stem cell factor (SCF )-stimulated lung MC expressed transcripts for interleukin-8 (IL-8), macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, or RANTES by Northern blotting. The mast cell line HMC-1, which contains a mutated and intrinsically activated SCF-receptor, was found to express high levels of MCP-1 mRNA in a constitutive manner. Exposure of HMC-1 cells to rhSCF resulted in upregulation of MCP-1 mRNA expression, and de novo expression of MIP-1beta mRNA. The SCF-induced upregulation of MCP-1 mRNA in lung MC and HMC-1 was accompanied by an increase in immunologically detectable MCP-1 in cell supernatants (sup) (lung MC [<98%], control medium, 1 hour: 159 +/- 27 v SCF, 100 ng/mL, 1 hour: 398 +/- 46 pg/mL/10(6) cells; HMC-1: control, 1 hour: 894 +/- 116 v SCF, 1 hour: 1,536 +/- 265 pg/mL/10(6)). IgE-dependent activation was also followed by MCP-1 release from MC. MC-sup and HMC-1-sup induced chemotaxis in blood monocytes (Mo) (control: 100% +/- 12% v 2-hour-MC-sup: 463% +/- 38% v HMC-1-sup: 532% +/- 12%), and a monoclonal antibody (MoAb) to MCP-1 (but not MoAb to IL-8) inhibited Mo-chemotaxis induced by MC-sup or HMC-1-sup (39% to 55% inhibition, P < .05). In summary, our study identifies MCP-1 as the predominant CC-chemokine produced and released in human lung MC. MCP-1 may be a crucial mediator in inflammatory reactions associated with MC activation and accumulation of MCP-1-responsive leukocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373254

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo.

Authors:  Sarah J Collington; Jenny Hallgren; James E Pease; Tatiana G Jones; Barrett J Rollins; John Westwick; K Frank Austen; Timothy J Williams; Michael F Gurish; Charlotte L Weller
Journal:  J Immunol       Date:  2010-04-28       Impact factor: 5.422

2.  Immunohistochemical study of hepatic oval cells in human chronic viral hepatitis.

Authors:  X Ma; D K Qiu; Y S Peng
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

3.  IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation.

Authors:  Matthew R Silver; Alexander Margulis; Nancy Wood; Samuel J Goldman; Marion Kasaian; Divya Chaudhary
Journal:  Inflamm Res       Date:  2009-09-18       Impact factor: 4.575

4.  CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.

Authors:  Georg Greiner; Nadine Witzeneder; Angelika Berger; Klaus Schmetterer; Gregor Eisenwort; Ana-Iris Schiefer; Simone Roos; Theresia Popow-Kraupp; Leonhard Müllauer; Johannes Zuber; Veronika Sexl; Lukas Kenner; Wolfgang R Sperr; Peter Valent; Matthias Mayerhofer; Gregor Hoermann
Journal:  Blood       Date:  2016-11-16       Impact factor: 22.113

5.  Role of immunoreactions and mast cells in pathogenesis of human endometriosis--morphologic study and gene expression analysis.

Authors:  Ryo Konno; Hisafumi Yamada-Okabe; Hiroyuki Fujiwara; Ichiro Uchiide; Hiroaki Shibahara; Michitaka Ohwada; Tomomi Ihara; Masao Sugamata; Mitsuaki Suzuki
Journal:  Hum Cell       Date:  2003-09       Impact factor: 4.174

6.  Direct activation of mast cells by prosthetic biomaterial particles.

Authors:  N Al-Saffar; H Iwaki; P A Revell
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

7.  Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses.

Authors:  A A Berlin; P Lincoln; A Tomkinson; N W Lukacs
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

8.  CD72 negatively regulates KIT-mediated responses in human mast cells.

Authors:  Tatsuki R Kataoka; Atsushi Kumanogoh; Geethani Bandara; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2010-01-25       Impact factor: 5.422

9.  Ischemia-reperfusion injury and pregnancy initiate time-dependent and robust signs of up-regulation of cardiac progenitor cells.

Authors:  Rami Genead; Helene Fischer; Alamdar Hussain; Marie Jaksch; Agneta B Andersson; Karin Ljung; Ivana Bulatovic; Anders Franco-Cereceda; Elzafir Elsheikh; Matthias Corbascio; C I Edvard Smith; Christer Sylvén; Karl-Henrik Grinnemo
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

10.  Genome-wide association with select biomarker traits in the Framingham Heart Study.

Authors:  Emelia J Benjamin; Josée Dupuis; Martin G Larson; Kathryn L Lunetta; Sarah L Booth; Diddahally R Govindaraju; Sekar Kathiresan; John F Keaney; Michelle J Keyes; Jing-Ping Lin; James B Meigs; Sander J Robins; Jian Rong; Renate Schnabel; Joseph A Vita; Thomas J Wang; Peter W F Wilson; Philip A Wolf; Ramachandran S Vasan
Journal:  BMC Med Genet       Date:  2007-09-19       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.